SCOPUS 정보 검색 플랫폼

Volumn 34, Issue 6, 1998, Pages 501-502

Clonidine: Adverse responses

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE;

ATTENTION DEFICIT DISORDER; CHILD PSYCHIATRY; DRUG EFFECT; DRUG OVERDOSE; HUMAN; NOTE; PEDIATRICS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY;

EID: 0032444915 PISSN: 10344810 EISSN: None Source Type: Journal
DOI: 10.1046/j.1440-1754.1998.00311.x Document Type: Note

Times cited : (3)

References (8)

1
- 0021818304
- Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double‐blind‐ placebo‐crossover therapeutic trial.
- 1 Hunt RD, Ruud B, Minderaa RB, Cohen DJ Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double‐blind‐ placebo‐crossover therapeutic trial. J. Am. Acad. Child Psychiatry 1985 ; 24: 617–29
- (1985) J. Am. Acad. Child Psychiatry , vol.24 , pp. 617-29
- Hunt, RD¹ Ruud, B² Minderaa, RB³ Cohen, DJ⁴

2
- 85010117149
- Clonidine in child and adolescent psychiatry.
- 2 Hunt RD, Capper L, O’Connell P Clonidine in child and adolescent psychiatry. J. Child Adolesc. Psychopharmacol. 1990 ; 1: 87–101
- (1990) J. Child Adolesc. Psychopharmacol. , vol.1 , pp. 87-101
- Hunt, RD¹ Capper, L² O’Connell, P³

3
- 0029585420
- Clonidine in the treatment of ADHD. questions about safety and efficacy.
- 3 Swanson JM, Flockart D, Udrea D, Cantwel Cantwel, DP DP, Connor D, Williams L Clonidine in the treatment of ADHD. questions about safety and efficacy. J. Child Adolesc. Psychopharmacol. 1995 ; 5: 301–4
- (1995) J. Child Adolesc. Psychopharmacol. , vol.5 , pp. 301-4
- Swanson, JM¹ Flockart, D² Udrea, D³ Cantwel, Cantwel⁴ DP, DP⁵ Connor, D⁶ Williams, L⁷

4
- 8544249459
- Methylphenidate and clonidine.
- 4 Walkup JT Methylphenidate and clonidine. Am. Acad. Child Adolesc. Psychiatry News 1995 ; 26: 11–2
- (1995) Am. Acad. Child Adolesc. Psychiatry News , vol.26 , pp. 11-2
- Walkup, JT¹

5
- 0030035649
- Combined pharmacotherapy or polypharmacy.
- 5 Levy F, Einfeld S, Looi J Combined pharmacotherapy or polypharmacy. J. Paediatr. Child Health. 1996 ; 32: 265–6
- (1996) J. Paediatr. Child Health. , vol.32 , pp. 265-6
- Levy, F¹ Einfeld, S² Looi, J³

6
- 0025915325
- Fluoxetine and norfluoxetine are potent inhibitors of P450–1006—the source of the spartene/debrisoquine oxidation polymorphism.
- 6 Brosen K & Skelbo E Fluoxetine and norfluoxetine are potent inhibitors of P450–1006—the source of the spartene/debrisoquine oxidation polymorphism. Br. J. Clin. Pharmacol. 1991 ; 32: 136–7
- (1991) Br. J. Clin. Pharmacol. , vol.32 , pp. 136-7
- Brosen, K¹ Skelbo, E²

7
- 0030892740
- Case study: Adverse response to clonidine.
- 7 Cantwell DP, Swanson J, Connor DF Case study: Adverse response to clonidine. J. Am. Acad. Child Adolesc. Psychiatry. 1997 ; 36: 539–44
- (1997) J. Am. Acad. Child Adolesc. Psychiatry. , vol.36 , pp. 539-44
- Cantwell, DP¹ Swanson, J² Connor, DF³

8
- 0019212374
- Clonidine ameloriates Gilles de la Tourette syndrome.
- 8 Cohen IJ, Detlor J, Young JG, Shawitz RA Clonidine ameloriates Gilles de la Tourette syndrome. Arch. Gen. Psychiat. 1980 ; 34: 1350–7
- (1980) Arch. Gen. Psychiat. , vol.34 , pp. 1350-7
- Cohen, IJ¹ Detlor, J² Young, JG³ Shawitz, RA⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.